Abstract
Cell Rep. 2026 Nov 16;45(11):118311. doi: 10.1016/j.celrep.2026.118311. Online ahead of print.
ABSTRACT
A-Kinase Anchoring Protein 11 (AKAP11) is a shared genetic risk factor for schizophrenia and bipolar disorder with poorly understood brain function. Through multi-omic analysis of Akap11 mutant mouse brains and astrocytes, we identify significant transcriptomic, proteomic, and metabolomic alterations. We observe upregulated cholesterol and fatty acid metabolism, elevated cAMP/PKA signaling, and accumulation of cholesteryl esters, triacylglycerols, ceramides, and glycerophospholipids, manifesting as increased lipid droplets in mutant astrocytes. Mechanistically, AKAP11 functions as an autophagy receptor mediating PKA degradation, requiring interaction with ER-resident VAP proteins to regulate lipid homeostasis. In neuron-astrocyte co-culture, astrocytic Akap11 loss increases excitatory neurotransmission and activity in human iPSC-derived neurons. In vivo, pharmacologic targeting of lipid metabolism partially reduces lipid accumulation in Akap11 mutant brains, whereas lithium carbonate further exacerbates this accumulation. Collectively, these findings link AKAP11-mediated lipid and synaptic dysregulation to psychiatric disease risk, highlighting the potential role of astrocytes in these disorders.
PMID:43043755 | DOI:10.1016/j.celrep.2026.118311